Examples of using Cisplatin in English and their translations into Russian
{-}
-
Official
-
Colloquial
In 4 and 6 hours cells became stained only when exposed with cisplatin at concentrations over 416.7 μmol/L.
such as copper sulfate, apomorphine, cisplatin, and motion.
has since gained popularity in clinical treatment due to its vastly reduced side effects compared to its parent compound cisplatin.
It was successfully used to study the apoptosis of tumor cells after cyclophosphamide and cisplatin therapy in mice by PET.
The hypocalcaemia seems to occur in those with low serum magnesium secondary to cisplatin, so it is not primarily due to the cisplatin.
Cisplatin solution at final concentration corresponding to IC 50 according to МТТ assay was added directly in culture medium.
The time of exposure with cisplatin in the concentration corresponding to IC 50(8.3 μmol/L)
using combination of mitomycin C and cisplatin.
Comparison of sensibility of the two cell lines to the effect of cisplatin showed that transfection of the cells with the fluorescent protein results in the increase of the sensitivity to cisplatin.
In control, DMEM medium with 2 mmol/L glutamine with 10% FBS without cisplatin was added to the cells.
using the combination of Herceptin, cisplatin and capecitabine is presented.
acquired resistance to cisplatin.
toxi-city of 3 cycles of intravenous dose-intensive NACT according to the AP scheme(cisplatin 75 mg/m2,
The clinical standard of dosage of carboplatin is usually a 4:1 ratio compared to cisplatin; that is, for a dose that usually requires a particular dose of cisplatin, four times as much carboplatin is needed to achieve the same effectivenesscitation needed.
IEO S398/208 neoadjuvant chemotherapy with docetaxel, cisplatin and 5-fluorouracil(TPF) followed by radiotherapy
The results of a prospective study of the NACT of BRCA1-associated OC using combination of mitomycin C and cisplatin were compared to the retrospective data(n=62)
A comparative study of cisplatin effect in relation to HeLa Kyoto
patients received a combination of mitomycin C 10 mg/m2 and cisplatin 100 mg/m2 every 4 weeks in the neoadjuvant regimen.
PIAC with low doses of cisplatin and doxorubicin leads to an objective regression of the tumor
Methods used in our investigation do not allow identifying exactly the way HeLa Kyoto-HyPer2 cells death after cisplatin exposure because trypan blue stains both necrotic and apoptotic cells[16], but allow identification of dose-time parameters of the action.